Researchers at the Garvan Institute have developed a novel way to monitor drug response and resistance in pancreatic cancer, utilizing a mouse model that allows for the real time visualisation of the effect of drug treatment within tumours. The team at the Garvan...

2022 was another year of facing and overcoming challenges for people around the world. As we move into a new year, it is a good time to reflect on achievements and accomplishments. Throughout the year, the APGI has continued to support Pancreatic Cancer research...

In recognition of Pancreatic Cancer Awareness Month, this November iconic buildings over Australia will light up purple to raise awareness for the disease and to celebrate and honour survivors and loved ones. Pancreatic cancer is the third leading cause of cancer...

A new clinical trial for people with advanced pancreatic cancer, has now commenced in Australia. The trial led by Amplia Therapeutics, in collaboration with Professor Paul Timpson from the Invasion and Metastasis Lab at The Garvan Institute of Medical Research, will...

Pancreatic cancer is one of the most aggressive cancers and five-year survival rates are just 10%. A very small number of patients live longer, with less than 2% surviving more than 10 years after diagnosis. Researchers have been working to understand how this cancer...

The Avner Australian Pancreatic Cancer Matrix Atlas group (APMA) will investigate a potential new way to improve immunotherapy outcomes for patients with pancreatic cancer using a class of drug that can reduce the metabolic rewiring of the cancer cells thanks to a...

November is recognised as World Pancreatic Cancer Awareness Month. We take time to raise awareness of the disease, celebrate survivors and acknowledge pancreatic cancer research.     Pancreatic cancer has now become the third leading cause of cancer deaths...

A new approach to ‘prime’ the tumour environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer. In preclinical models, a team from the Invasion and Metastasis Lab at The Garvan...

Tanya Dwarte, Associate Genetic Counsellor and Clinical Research Coordinator at the APGI will give a presentation about Genetics and Pancreatic cancer. This webinar will highlight the current understanding of sporadic and inherited forms of pancreatic cancer and...

APGI BioResource Project Summary 2020   2020 has been a difficult year for everyone around the world. Our thoughts are with those who have suffered physically and emotionally this year. Despite the challenges here at the APGI we have maintained our commitment to...